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mutant function more precisely, and
additional patient recruitment would
be very helpful.
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TO THE EDITOR
The transcription factor p63 has been
shown to have a pivotal role during
ectodermal, orofacial, and limb devel-
opment (Mills et al., 1999; Yang et al.,
1999; Rinne et al., 2007). So far, muta-
tions in TP63 encoding p63 have been
linked to three major phenotypes: ecto-
dermal defects, split hand/foot malfor-
mation, or orofacial clefting (Celli et al.,
1999; van Bokhoven et al., 1999;
Ianakiev et al., 2000; McGrath et al.,
2001; Rinne et al., 2007). Ectodermal
dysplasia syndromes associated with
TP63 mutation are always inherited in
an autosomal dominant manner (Koster,
2010) and include the ectrodactyly,
ectodermal dysplasia, and cleft lip/
palate syndrome (EEC), the ankyloble-
pharon–ectodermal defects–cleft lip/
palate syndrome (AEC), the limb–
mammary syndrome, the acro–dermato–
ungual–lacrimal–tooth syndrome, and the
Rapp–Hodgkin syndrome (RHS; Rinne
et al., 2007). Through large-scale muta-
tion screening, several phenotype–geno-
type correlations have emerged: although
mutations altering the p63 DNA–binding
domain have been shown to cause EEC,
mutations affecting the sterile alpha-
motif domain of the protein cause mostly
AEC (Mills et al., 1999; Yang et al.,
1999; McGrath et al., 2001; Lo Iacono
et al., 2008; Koster, 2010). In the present
study, we identified a mutation affecting
a conserved residue of the p63 trans-
cription inhibitory (TI) domain causing a
phenotype previously unreported to the
best of our knowledge.Accepted article preview online 27 March 2014; published online 24 April 2014
Abbreviations: AEC, ankyloblepharon–ectodermal defects–cleft lip/palate syndrome; EEC, ectrodactyly,
ectodermal dysplasia, and cleft lip/palate syndrome; RHS, Rapp–Hodgkin syndrome; TI, transcription
inhibitory
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We assessed a family of Jewish
Ashkenazi origin. Patients presented
with a variable phenotype (Figure 1).
Most affected individuals demonstrated
hypodontia, diastema, dystrophic nails,
and thin and fragile skin on their feet. In
addition, some of the patients had
coarse and dry hair, and lower-lip pits.
Hypohydrosis was absent and psycho-
motor development was normal.
After having obtained informed writ-
ten consent according to a protocol
approved by our institutional review
board and by the Israel National Com-
mittee for Human Genetic Studies in
adherence with the declaration of Hel-
sinki Principles, genomic DNA was
extracted from peripheral blood lym-
phocytes obtained from affected and
healthy family members. Given the clin-
ical features displayed by the patients,
we searched for a causative mutation in
a panel of candidate genes previously
found to be associated with similar
clinical manifestations (Visinoni et al.,
2009). No mutations were identified in
the coding sequences of WNT10A,
PVRL1, FZD6, or IRF6 (for list of
primers, see Supplementary Table S1
online). In contrast, mutation analysis
identified a heterozygous missense
mutation in TP63, c.G1904T, predicted
to result in a single amino acid substitu-
tion, p.G635V (p.G596V, according to
previous nomenclature (Yang et al.,
1998); Figure 2a). Using direct sequenc-
ing, we confirmed cosegregation of the
mutation with the disease phenotype
throughout the entire family. The muta-
tion was not found in any major public
databases including in a total of more
than 8000 individual sequences depos-
ited in the 1000 Genomes Project
(http://www.1000genomes.org/) and in
the NHLBI Grand Opportunity Exome
Sequencing Project (http://evs.gs.
washington.edu/EVS/). Mutation p.G635V
affects a moderately well-conserved
amino acid residue (ConSurf score¼5;
range¼ 1–9; http://consurf.tau.ac.il;
Ashkenazy et al., 2010). The mutant
amino acid residue resides within the
TI domain. This domain is specific for
the p63 alpha isoforms, which are
required for ectodermal and limb deve-
lopment and for the maintenance of
mature skin (Wolff et al., 2009).
Therefore, we set out to examine the
effect of the mutation on the trans-
activating activity of p63.
We cloned wild-type p63 delta N
alpha (DNp63a) isoform into the
pcDNA-HA expression vector. We then
introduced c.G1904T into the p63 con-
struct using the Quick Change Site-
Directed Mutagenesis kit (Stratagene,
La Jolla, CA). The wild-type p63 con-
struct, the mutant p63 construct, or an
equal mixture of both constructs were
co-transfected into primary keratino-
cytes using Lipofectamine 2000 (Life
Technologies, Grand Island, NY)
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Figure 1. Clinical features. (a) Pedigree of the family. (b) Hyponychia and keratoderma in individual II-2. (c) Diastema and lower-lip pit in individual III-1.
(d) Coarse hair in individual III-1. (e) Palmoplantar keratoderma in individual II-2. (f) Nail dystrophy in individual III-3.
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together with a plasmid carrying the
C40 enhancer sequence (which con-
tains a highly conserved binding site
for the p63 protein (Antonini et al.,
2006)) located upstream to the luci-
ferase gene and with pRL-TK renilla
luciferase. Forty-eight hours after trans-
fection, luciferase activity was found to
be significantly suppressed in the
presence of the mutant p63 compared
with wild-type p63 (Figure 2b), suggest-
ing that p.G635V alters the transcrip-
tional regulation of p63 targets.
Of interest, p.G635V, which was found
in the present study to result in a loss-of-
function effect (Figure 2b), causes a con-
stellation of signs overlapping with, but
not identical to, RHS (Supplementary
Table S2 online) while affecting a region
of the gene in which nonsense/truncating
mutations have been shown to cause split
hand/foot malformation (Rinne et al.,
2007) and missense mutations have
been associated with the AEC pheno-
type (Rinne et al., 2009). Phenotypic
heterogeneity is typical of p63-associ-
ated syndromes and is thought to result
from the different biological effects of
alterations of the molecule’s various
domains, as well as from both inherited
and environmental modifying traits
(Vanbokhoven et al., 2011). In this
regard, as IRF6 can act as a modifier
gene (Gritli-Linde, 2010), increasing the
risk for cleft lip in individuals carrying
TP63 mutations, and given the fact that
some of our patients displayed lower-lip
pits (never previously reported to our
knowledge in p63 syndromes), we
excluded by direct sequencing any
pathogenic mutation in the coding
region of this gene in our patients, as
well as in its enhancer (not shown). The
fact that p63 regulates IRF6 (Moretti
et al., 2010) and that abnormal IRF6
activity leads to lip pit formation (Kondo
et al., 2002) may explain how TP63
mutations affect lip pit formation.
In summary, the present observations
expand the spectrum of clinical
manifestations associated with TP63
mutations and re-emphasize the need
for a better understanding of the mole-
cular basis of phenotypic heterogeneity
in p63 syndromes.
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TO THE EDITOR
Powassan virus (POWV) is an emerging
North American tick-borne flavivirus
transmitted to humans by infected tick
bites. Ticks transmit pathogens during
the complex feeding process of pene-
trating the skin and stay attached for
several days to acquire blood. This
process is facilitated by a repertoire of
pharmacologically active proteins/
factors in tick saliva (Ribeiro et al.,
2006; Kazimı´rova´ and Sˇtibra´niova´,
2013). Thus, skin acts as the interface
of the host–pathogen–vector interactions
(Wikel, 2013). Skin provides the first
line of defense against mechanical and
environmental damage and infectious
agents (Nestle et al., 2009). In a pre-
vious study, which examined cutaneous
bite-site lesions from uninfected Ixodes
scapularis nymphs, a rapid, proinflam-
matory progression of the early host
response was identified, culminating in
the infiltration of innate immune cells by
12 hours after tick infestation (Heinze
et al., 2012). Successful transmission of
tick-borne POWV has been shown to
occur within 15 minutes of I. scapularis
attachment (Ebel and Kramer, 2004).
In addition, it was demonstrated that
during early feeding time points the viral
load in the tick salivary glands increases
(Alekseev and Chunikhin, 1990). There-
fore, the early cutaneous interac-
tions between host immunity and
initial tick-mediated immunomodu-
lation are central to successful disease-
causing agent transmission. In this study,
we sought to characterize tick-induced
changes in cutaneous gene expression
at the early stages of attachment and
feeding by POWV-infected I. scapularis
nymphs. This will allow us to
demonstrate the effect of a tick-borne
virus on immune response at the tick–
host interface.
In this study, we generated POWV-
infected I. scapularis nymphs by
synchronous infection (McNally et al.,
2012) and allowed them to feed
on 6-week-old female Balb/C mice.
Uninfected ticks were used as control.
Each treatment group consisted of four
mice, each with a capsule containing
one tick. At least three out of four mice
had successful tick attachment at each
time point, providing us with sufficient
sample sizes to perform statistical
analyses. Three and six hours after tick
attachment (hours post infection, h.p.i.),
4 mm mouse skin biopsies were har-
vested along with the feeding ticks.
Ticks and skin were checked for
POWV infection, and all the infected
ticks/skin biopsies used in this experi-
ment contained POWV RNA. Total RNA
was extracted from each skin biopsy
and cutaneous immune responses were
analyzed by pathway-specific PCR
arrays (Supplementary Table S1 online).
In total, 456 genes were analyzed with
these arrays. Relative fold differences
of the immune genes were calculated
as previously described (Heinze et al.,
2012). These data were then uploaded
to ingenuity pathway analysis software
for further analysis. Comparative analysis
between POWV-infected and uninfected
tick attachment sites at 3 and 6 h.p.i.
was performed (Supplementary Table S2
online). When all significantly modulated
(Pp0.05) host genes in the uninfected
versus POWV-infected 3 h.p.i. tick-
feeding sites were taken into account,
there were 40 upregulated genes and
11 downregulated genes (Figure 1a). Of
all significantly modulated host genes in
the 6 h.p.i. uninfected versus POWV-Accepted article preview online 21 March 2014; published online 17 April 2014
Abbreviations: POWV, Powassan virus; TNF, tumor necrosis factor
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